Clinical Research Directory
Browse clinical research sites, groups, and studies.
Pediatric Prospective Personalized Immune and Target Identification Trial
Sponsor: Masaryk University
Summary
PPROSPERITIT is a prospective clinical study assessing the use of comprehensive molecular profiling to define the best matching targeted and immune treatment for relapsed, refractory or very high risk pediatric CNS tumors.
Official title: Prospective, Interventional Diagnostic, Multicenter, Non-treatment Clinical Study Identifying Specific Molecular Changes by Using Genomic Sequencing Technologies in Refractory/Recurrent or Very High-risk Pediatric CNS Tumors.
Key Details
Gender
All
Age Range
1 Year - 19 Years
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2021-02-02
Completion Date
2024-12-10
Last Updated
2026-05-01
Healthy Volunteers
No
Interventions
FoundationOneHeme
Tumor tissue obtained during standard surgery will be subsequently examined histopathologically and the content of cancer cells will be determined. Broad molecular profiling of the tumor; with potential results finding such molecular changes, for which the specific targeted anti-tumor treatment will be performed.
Locations (3)
Medical University of Vienna
Vienna, Spitalgasse 23,, Austria
Motol University Hospital
Prague, V Úvalu 84,, Czechia
University Hospital Brno
Brno, Černopolní 9,, Czechia